KYNMOBI: payments to doctors
Payments that named KYNMOBI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $689K
- Providers
- 3,763
- Transactions
- 16,223
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,763 providers the average total is $183, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | $688,697 | 100.0% |
| Sumitomo Pharma America, Inc. | $169 | 0.0% |